12 Health Care Stocks Moving In Monday's Intraday Session
12 Health Care Stocks Moving In Monday's Intraday Session
週一盤中交易時段,12只醫療保健類股走勢
Gainers
獲勝者
- Bionomics (NASDAQ:BNOX) stock moved upwards by 32.7% to $2.03 during Monday's regular session. Trading volume for Bionomics's stock is 3.0 million as of 13:30 EST. This is 4392.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $16.5 million.
- XTL Biopharmaceuticals (NASDAQ:XTLB) stock moved upwards by 28.2% to $1.0. The company's market cap stands at $5.4 million.
- Akebia Therapeutics (NASDAQ:AKBA) stock rose 23.35% to $1.42. Akebia Therapeutics's stock is trading at a volume of 3.5 million shares as of 13:30 EST. This is 173.0% of its average full-day volume over the last 100 days. The company's market cap stands at $263.7 million. As per the news, the Q2 earnings report came out yesterday.
- PHAXIAM Therapeutics (NASDAQ:PHXM) stock rose 19.99% to $0.63. The market value of their outstanding shares is at $38.2 million.
- Prenetics Global (NASDAQ:PRE) shares rose 17.76% to $0.54. Trading volume for this security as of 13:30 EST is 202.1K, which is 166.7% of its average full-day volume over the last 100 days. The company's market cap stands at $97.6 million.
- MSP Recovery (NASDAQ:LIFW) stock increased by 17.29% to $0.08. As of 13:30 EST, this security is trading at a volume of 10.6 million shares, making up 1580.1% of its average full-day volume over the last 100 days. The company's market cap stands at $25.9 million.
- 生物學 納斯達克股票代碼:BNOX)股價在週一的例會上漲32.7%,至2.03美元。截至美國東部標準時間 13:30,Bionomics的股票交易量爲300萬股。這是其過去100天平均全天交易量的4392.4%。他們流通股的市值爲1,650萬美元。
- XTL 生物製藥 納斯達克股票代碼:XTLB)股價上漲28.2%,至1.0美元。該公司的市值爲540萬美元。
- 阿克比亞療法 納斯達克股票代碼:AKBA)股價上漲23.35%,至1.42美元。截至美國東部標準時間13點30分,Akebia Therapeutics的股票交易量爲350萬股。這是其過去100天平均全天交易量的173.0%。該公司的市值爲2.637億美元。消息稱,第二季度收益報告已於昨天發佈。
- PHAXIAM 治療藥 納斯達克股票代碼:PHXM)股價上漲19.99%,至0.63美元。他們流通股的市值爲3,820萬美元。
- Prenetics 全球 納斯達克股票代碼:PRE)股價上漲17.76%,至0.54美元。截至美國東部標準時間 13:30,該證券的交易量爲20.21萬,佔其過去100天平均全天交易量的166.7%。該公司的市值爲9,760萬美元。
- MSP 恢復 納斯達克股票代碼:LIFW)股價上漲17.29%,至0.08美元。截至美國東部標準時間 13:30,該證券的交易量爲1,060萬股,佔其過去100天平均全天交易量的1580.1%。該公司的市值爲2590萬美元。
Losers
失敗者
- NovoCure (NASDAQ:NVCR) stock decreased by 35.1% to $19.33 during Monday's regular session. The current volume of 9.0 million shares is 538.0% of NovoCure's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $2.0 billion.
- Longeveron Inc. - Subscription Right (NASDAQ:LGVNR) shares fell 28.89% to $0.02. The current volume of 195.2K shares is 46.5% of Longeveron Inc. - Subscription Right's average full-day volume over the last 100 days (last updated at 13:30 EST).
- Opthea (NASDAQ:OPT) shares fell 19.82% to $2.59. Trading volume for this security as of 13:30 EST is 91.3K, which is 1157.3% of its average full-day volume over the last 100 days. The company's market cap stands at $151.1 million.
- Aditxt (NASDAQ:ADTX) stock decreased by 16.8% to $7.58. Trading volume for this security as of 13:30 EST is 60.9K, which is 84.1% of its average full-day volume over the last 100 days. The company's market cap stands at $1.4 million.
- SAB Biotherapeutics (NASDAQ:SABS) stock decreased by 16.42% to $0.56. The market value of their outstanding shares is at $29.2 million.
- Novo Integrated Sciences (NASDAQ:NVOS) stock decreased by 13.87% to $0.15. The current volume of 20.7 million shares is 87.3% of Novo Integrated Sciences's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $21.8 million. See Also:
- NovoCure 納斯達克股票代碼:NVCR)股價在週一的例會上下跌35.1%,至19.33美元。目前的900萬股成交量佔NovoCure過去100天平均全天成交量的538.0%(最後更新時間爲美國東部標準時間 13:30)。他們流通股的市值爲20億美元。
- Longeveron Inc.-訂閱權 納斯達克股票代碼:LGVNR)股價下跌28.89%,至0.02美元。目前的19.52萬股成交量爲Longeveron Inc.——Subscription Right在過去100天內平均全天交易量的46.5%(最後更新時間爲美國東部標準時間13點30分)。
- Opthea 納斯達克股票代碼:OPT)股價下跌19.82%,至2.59美元。截至美國東部標準時間 13:30,該證券的交易量爲91.3萬,佔其過去100天平均全天交易量的1157.3%。該公司的市值爲1.511億美元。
- aditxt 納斯達克股票代碼:ADTX)股價下跌16.8%,至7.58美元。截至美國東部標準時間 13:30,該證券的交易量爲60.9萬,佔其過去100天平均全天交易量的84.1%。該公司的市值爲140萬美元。
- SAB 生物療法 納斯達克股票代碼:SABS)股價下跌16.42%,至0.56美元。他們流通股的市值爲2920萬美元。
- Novo 綜合科學 納斯達克股票代碼:NVOS)股價下跌13.87%,至0.15美元。目前的2,070萬股成交量佔Novo Integrated Sciences過去100天平均全天成交量的87.3%(最後更新時間爲美國東部標準時間13點30分)。該公司的市值爲2180萬美元。 另請參閱:
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動內容引擎生成,並由編輯審閱。